User-centered design and related participatory approaches in digital health innovations for low-resource settings: A scoping review protocol Authors: Emmanuel Otukpa, Abdhalla Ziraba, Christopher Pell, Ben Ngoye, Helen Howard, Alejandro Mac Cawley, Alejandro Mac Cawley, Alejandro Mac Cawley Published: 2026 ABSTRACT ObjectiveThe primary objective of this scoping review is to identify and synthesize the existing evidence on the applications, reported outcomes, and key methodological considerations of user-centered design (UCD) and related participatory design methodologies including human centered design (HCD), co-design, participatory design and co-creation of digital health innovations within resource constrained settings.IntroductionA critical challenge in global health is the high failure rate of technologically sound innovations. This is due in part to insufficient consideration of the end-user’s environment, literacy levels, and socio-cultural beliefs. UCD is an iterative design process that grounds development in an understanding of the user’s needs, contexts, and feedback. It sits within a wider family of related approaches such as HCD, co-design, participatory designs and co-creation, while related to UCD, is distinguished by its emphasis on equitable partnership, where end-users are not merely informants but co-designers and co-developers of the innovation. These approaches have emerged as promising methodologies to develop more relevant, acceptable, and sustainable digital health solutions. In disease diagnostics, despite increasing interest, there is lack of a consolidated review mapping the full scope of how these methodologies are applied, across which types of digital health and diagnostic innovations, and with what outcomes.Inclusion criteriaStudies conducted in low-resource settings, published between 2015 and 2026 that apply UCD or a related participatory design methodology to the development, adaptation or evaluation of a digital health innovation and, where reported, outcomes such as usability, patient satisfaction, innovation success, adoption, scalability and sustainability. Studies that name such an approach without describing the activities undertaken are also eligible, and the completeness of reporting will be recorded and reported as a finding of this review.MethodsGuided by the JBI methodology for scoping reviews and reported in accordance with PRISMA-ScR, we will search MEDLINE, Embase, CINAHL, Scopus, Web of Science, IEEE Xplore, the ACM Digital Library, the WHO Global Index Medicus, and Google Scholar, together with named grey literature sources, for peer-reviewed articles, conference proceedings, and grey literature published in English and French from 2015 to 2026. Data extraction will include information on study characteristics, the design approaches and processes applied, the completeness with which they are reported as well as the outcomes. Introduction A disproportionate number of preventable diseases, including both communicable and non-communicable diseases (NCDs), occur in low-resource environments worldwide [1,2]. Much of this burden is preventable or manageable with timely, accurate diagnosis and care, yet health-system constraints in infrastructure, financing, and workforce limit access to such care. These conditions range from communicable diseases, such as malaria, neglected tropical diseases, and zoonotic infections, to a rising burden of non-communicable diseases including cardiovascular disease, diabetes, and mental-health conditions [3]. These diseases are responsible for a substantial share of deaths worldwide, with the burden concentrated in low- and middle-income countries (LMICs) [3]. Part of this is a result of persistent health systems constraints in these settings, which is characterized by infrastructure, financial and human resource constraints that limit the adoption and impact of medical and diagnostic technologies analyses of health systems in sub-Saharan Africa document these constraints in detail [4]. In recent years, there has been a growing recognition of the potential of digital health technology to address healthcare concerns, in low-resource settings [5]. Telemedicine platforms enable remote consultations, allowing patients in underserved areas to receive medical advice without the need for long-distance travel [6]. Additionally, mobile health (mHealth) interventions leverage the widespread use of mobile phones to disseminate health information, send appointment reminders, and support medication adherence [7,8]. Digital health innovations span a wide range of applications relevant to low-resource settings. These include diagnostic tools such as smartphone-based microscopy and AI-assisted image analysis for malaria and schistosomiasis [9,10]; clinical decision support systems that assist providers in identifying antimicrobial-resistant organisms and selecting appropriate treatment regimens, with implications for antimicrobial stewardship [11]; digitally enabled point-of-care testing, which may help close diagnostic service gaps in underserved and remote areas [12–14]; and wearable sensors supporting continuous monitoring of chronic conditions, allowing a shift from episodic, clinic-based measurement towards remote monitoring and risk-based triage [15–19]. What these applications share is that their potential is contingent on use. Technical performance established under controlled conditions does not by itself determine whether a tool is adopted, used correctly, or sustained in the settings where it is deployed. It is this gap between demonstrated capability and realized benefit that motivates attention to how such technologies are designed. The high failure rate of technologically sound innovations that are implemented without adequate attention to the end-user’s environment, literacy levels, and sociocultural attitudes is a key concern in global health. [9,20]. Health technologies, including diagnostic tools, developed for high-income settings often fail when transferred directly to low-resource contexts partly due to a mismatch with local needs, capacities, and cultural realities [20]. Non-adoption and abandonment are neither marginal nor random: they arise from the interaction between a technology and the organizational, infrastructural, and social conditions of its setting, and are therefore in principle, addressable at the design stage A paradigm shift is provided by User-Centered Design (UCD) and related participatory approaches, which move from a top-down technology transfer model to a collaborative process that actively incorporates end-users throughout the development lifecycle, including patients, community health workers, and local clinicians. [7,10]. UCD is an iterative design methodology that centers product development around users, ensuring that their requirements, preferences, and feedback influence each stage of the design cycle [11]. This process has been reported to enhance usability and to increases user satisfaction and engagement with health technologies [11,12]. Key principles of UCD include a deep understanding of user requirements, active user involvement in evaluations, and iterative testing and refinement of designs based on user input [13]. UCD belongs to a family of related methodologies that place users at the center of technology development: human-centered design (HCD), participatory design, co-design, co-creation, and design thinking. HCD is used largely synonymously with UCD, though often framed more expansively around the wider system of people, institutions, and social conditions surrounding a technology rather than the individual end-user alone [21]. Participatory design is grounded in a normative commitment to the right of those affected by a system to shape it, and co-design and co-creation extend this furthest, positioning users not as informants but as partners holding decision-making authority over the design of the innovation [12,14,22]. Working definitions and sources for each term are given in Table 1. 10.1371/journal.pone.0337671.t001Table 1Working definitions of user-involving design approaches used in this review.TermWorking definitionDistinguishing emphasisKey sourceUser-centred design (UCD)Iterative design process in which users’ requirements, contexts, and feedback shape each stage of the design cycle.Usability and fit to user needs; users as a source of requirements and evaluation.Norman & Draper [23]; Gulliksen et al. [13]Human-centred design (HCD)Largely synonymous with UCD, but often extended to the wider system of people, institutions, and social conditions surrounding a technology.Systemic framing beyond the individual end-user.Göttgens & Oertelt-Prigione [21]Participatory designDesign process grounded in the right of those affected by a system to influence its design.Normative commitment to democratic participation.Papoutsi et al. [24]Co-designCollaborative design in which users work alongside developers as active contributors to design decisions.Shared authorship of design outputs.Osterheider et al. [14]Co-creationEquitable partnership in which users hold decision-making authority as co-designers and co-developers.Depth of partnership and shared control.Hardyman et al. [22]Design thinkingStructured problem-solving orientation, typically organised into discrete phases, within which the above methods are deployed.Process architecture rather than a specific mode of user involvement.Chen et al. [25] Working definitions of user-involving design approaches used in this review. What unites these approaches is iterative development grounded in users lived contexts; what distinguishes them is chiefly the depth of user involvement, which ranges along a continuum from consultation to equitable partnership. In practice the labels are applied inconsistently and often interchangeably [21,26]. It is for this reason that this review is framed around the family of approaches as a whole, rather than around any single named method, and that eligibility is determined by the user-involvement activities a study describes rather than by the term it uses. Throughout this protocol we use “UCD and related participatory design methodologies” to denote this family and reserve the specific terms for instances where a specific approach is meant. Working definitions are summarized in Table 1. By emphasizing user experiences and actively involving patients or clients in the design process, these approaches may result in solutions that are not only practical but also accessible and egalitarian [14,24]. During the COVID-19 pandemic, healthcare organizations utilized human-centered design (HCD) approaches to rapidly develop and adapt digital tools aimed at improving access to care for underserved populations [7,27]. Such accounts illustrate how these approaches have been applied to support timely interventions and better resource allocation during health crises, although the evidence for their effect on outcomes remains dispersed and inconsistently reported. Rationale for the review Implementing digital health innovations in LMICs is made more difficult by the absence of a thorough map of the models, processes, and reported results of UCD and related participatory design methodologies as they are applied in these contexts. These settings present distinctive realities, including constrained infrastructure, heterogeneous digital and health literacy, intermittent connectivity, and diverse socio-cultural and linguistic contexts; that strongly shape whether digital health and diagnostic innovations are adopted and sustained. UCD and related participatory approaches are well suited to navigating precisely these realities, because they ground design in users’ lived contexts and constraints rather than in assumptions imported from high-resource settings. What remains unclear is therefore not whether these approaches can be applied in low-resource settings, but how they are applied: which methods, at which stages of development, and with which stakeholders and with what reported outcomes. This evidence remains scattered and has not been consolidated. Current literature indicates that while examples of participatory practice exists, such as participatory design initiatives in rural settings. A concrete and widely applicable framework for integrating these approaches in such contexts remains underdeveloped [23]. Without systematic documentation of how these approaches are applied and with what results, it is difficult to identify transferable practice, to replicate approaches that have worked elsewhere, or to judge which elements of a design process account for reported outcomes. Mapping this evidence is a precondition for any of these. We include the full family of user-involving design approaches rather than a single named method because the terminology is used inconsistently across this literature: studies applying substantively similar methods describe them variously, and studies invoking the same label may describe very different depths of user involvement. Restricting the review to one or two labels would therefore fragment a body of evidence that is methodologically continuous and would systematically miss relevant work. Within digital health, this review gives particular attention to diagnostic applications, reflecting both the persistent diagnostic gap in low-resource settings and the focus of the wider DI-DIDA project under which this review is conducted. Diagnostic applications are treated as one category of digital health innovation rather than as a separate scope. Objectives The core objective of this review is to map the evidence on UCD and related participatory design methodologies in the development of digital health innovations, focusing on how these approaches are applied and what outcomes are reported in low-resource settings. A secondary objective is to characterize how completely these design processes are reported. Review questions Through this review we will attempt to provide responses to the following questions: What participatory and user-involving design approaches including UCD, HCD, co-design, participatory design, and co-creation and which named frameworks, processes, or models (e.g., the Double Diamond, IDEAS, the ISO 9241−210 cycle) are applied in the development of digital health innovations for low-resource settings, and how does their use vary across regions, healthcare contexts, and technology types? What participatory and user-involving design approaches including UCD, HCD, co-design, participatory design, and co-creation and which named frameworks, processes, or models (e.g., the Double Diamond, IDEAS, the ISO 9241−210 cycle) are applied in the development of digital health innovations for low-resource settings, and how does their use vary across regions, healthcare contexts, and technology types? How are participatory and user-involving design processes reported to influence the design and functionality of digital health innovations in low-resource settings at which stages of the development lifecycle, using which methods, with which stakeholder groups, and at what depth of user involvement? How are participatory and user-involving design processes reported to influence the design and functionality of digital health innovations in low-resource settings at which stages of the development lifecycle, using which methods, with which stakeholder groups, and at what depth of user involvement? What outcomes intended and unintended (e.g., usability, acceptability, adoption, clinical accuracy, scalability, sustainability) are reported in association with these approaches in digital health innovations in low-resource settings, and how are these outcomes measured and reported? What outcomes intended and unintended (e.g., usability, acceptability, adoption, clinical accuracy, scalability, sustainability) are reported in association with these approaches in digital health innovations in low-resource settings, and how are these outcomes measured and reported? How completely are participatory design processes reported in this literature, and what proportion of studies invoke a named approach without describing the activities undertaken? How completely are participatory design processes reported in this literature, and what proportion of studies invoke a named approach without describing the activities undertaken? Inclusion criteria Population/setting. For the purposes of this review, a low-resource setting is defined as one in which the design and deployment of digital health innovations is materially constrained by limitations in infrastructure, health workforce, financing, connectivity, or population-level digital and health literacy, or by structural barriers to healthcare access. Studies are eligible if conducted in (i) a country classified by the World Bank as low-income, lower-middle-income, or upper-middle-income at the time the study was conducted; or (ii) a defined population or geographic area within a high-income country, where both of the following apply: (a) the study explicitly frames the innovation as responding to resource constraints or structural barriers to access affecting that population; and (b) the population corresponds to at least one externally defined designation of underservice or deprivation, as listed in S2 Table. Meeting criterion (b) alone is not sufficient: rurality or low income, without a stated resource-constraint rationale, does not render a study eligible. Studies of general populations in high-income countries are excluded. Where a study spans multiple settings, it is eligible if data relating to an eligible setting can be separately identified. Eligible countries will be identified using the World Bank income classification for fiscal year 2020; the full country list is reproduced in Appendix I. Where a country’s classification changed during the study period, eligibility is determined by its classification at the time the study was conducted; where the year of conduct cannot be determined, the classification at the year of publication is applied and recorded during extraction. Within these settings, the review focuses on studies that apply UCD or a related participatory design methodology to the development, adaptation, or evaluation of a digital health innovation, and that report, where available, outcomes such as usability, patient satisfaction, innovation success, adoption, scalability, and sustainability. Context. Digital health interventions, including but not limited to: Digitally enabled diagnostics and point-of-care testing (e.g., smartphone-based microscopy, AI-assisted image interpretation, connected or reader-based point-of-care tests, digital diagnostic decision support). Digitally enabled diagnostics and point-of-care testing (e.g., smartphone-based microscopy, AI-assisted image interpretation, connected or reader-based point-of-care tests, digital diagnostic decision support). eHealth (web-based applications). eHealth (web-based applications). mHealth (mobile health applications). mHealth (mobile health applications). Telemedicine or telehealth platforms. Telemedicine or telehealth platforms. Wearable health technologies Wearable health technologies Diagnostic tests without a digital component (e.g., conventional lateral-flow rapid diagnostic tests read by eye) are not eligible unless the innovation includes a digital element such as automated reading, image capture and analysis, connectivity, or data capture. Diagnostic tests without a digital component (e.g., conventional lateral-flow rapid diagnostic tests read by eye) are not eligible unless the innovation includes a digital element such as automated reading, image capture and analysis, connectivity, or data capture. Types of studies. This review aims to explore empirical studies (quantitative, qualitative, or mixed methods) and eligible grey literature, including conference proceedings, technical reports, and dissertations. Existing systematic reviews, scoping reviews, and meta-analyses will not be included as primary results; instead, their reference lists will be screened to identify relevant primary studies for inclusion, and they may be drawn on for background and contextual discussion. To be eligible, a study must report the development, adaptation, or evaluation of a digital health innovation in a low-resource setting, and must meet at least one of the following: (a) it describes at least one concrete user-involvement activity (e.g., interviews, focus groups, contextual inquiry, participatory prototyping, co-design workshops, or usability testing) with end-users or other relevant stakeholders at one or more stages of development; or (b) it explicitly claims the use of a named user-involving design approach including UCD, HCD, co-design, co-creation, participatory design, or design thinking without describing the associated activities. Studies meeting only criteria (b) are retained deliberately: the inconsistent and sometimes nominal use of this terminology is itself a recognized feature of the field, and quantifying its extent is an objective of this review. Each included study will be classified during extraction according to the completeness with which the design process is reported (fully described, partially described, or label-only), and this classification will be reported as a finding. Label-only studies will be analyzed as a distinct stratum and excluded from the synthesis of methods, stages, and depth of involvement, which they cannot inform. Approaches applied to the design or development of a digital health innovation are eligible; participatory approaches applied solely to service delivery, health promotion, or research governance, with no associated technology, are not. Formal evaluation or outcome measurement is not required for inclusion, and the presence or absence of outcome reporting will be recorded during extraction. Publication characteristics. We will focus on English and/or French literature published in peer-reviewed journals or as grey literature from recognized organizations (e.g., WHO, government bodies). We will include studies published between 1 January 2015 and 31 December 2026; studies published outside this window will be excluded. This 11-year window is applied as a database-level limit at the search stage and is intended to capture the period of rapid scale-up of digital health and point-of-care diagnostic technologies, aligned with the era framed by the WHO Global Strategy on Digital Health (2020–2025), so that the evidence remains relevant to current technologies and design practice. Methods This scoping review will be conducted in accordance with the JBI methodology for scoping reviews, with the overarching goal of mapping, clarifying, and identifying knowledge and methodological gaps, and will be reported in accordance with PRISMA-ScR and, for the search, PRISMA-S. The process involves a systematic approach to searching, screening, and reporting encompassing the following stages:: (1) identification of the research question (s); (2) identification of relevant databases and studies; (3) selection of studies; (4) data extraction; (5) interpretation, summarization and dissemination of the results. This approach is preferable as expected literature will report heterogenous methods and outcomes that may not be quantitatively pooled statistically into a single measure. The protocol has been registered on the Open Science Framework [25] Search strategy Our search strategy aims to locate both published and unpublished studies. A three-step search strategy is being used. First, an initial limited search of MEDLINE (PubMed) and CINAHL (EBSCOhost) was conducted to identify articles on the topic. The text words contained in the titles and abstracts of relevant articles, and the index terms used to describe them, were used to develop the full search strategy, which is presented in Appendix I. Second, that strategy, including all identified keywords and index terms, has been adapted for each included database and information source. Third, the reference lists of all included sources of evidence will be screened for additional studies. We will search for peer-reviewed and grey literature published in English and French between 1 January 2015 and 31 December 2025, without methodological restrictions. The databases and information sources to be searched are specified in Table 2, and the grey literature sources and the approach taken to each are specified in Table 3. The complete, untruncated search string for every source, together with the date on which it was run and the number of records retrieved, is reported in Appendix I in accordance with PRISMA-S. An overview of the search structure is presented in Table 4. 10.1371/journal.pone.0337671.t002Table 2Databases and information sources to be searched.Database/ sourcePlatform or interfaceCoverage searchedRationaleMEDLINEPubMed2015-2026Core biomedical literatureEmbaseElsevier2015-2026Broader European and pharmacological coverageCINAHLEBSCOhost2015-2026Nursing, allied health, and community health worker literatureScopusElsevier2015-2026Multidisciplinary coverage, including conference outputWeb of Science Core CollectionClarivate2015-2026Multidisciplinary coverage and citation searchingIEEE XploreIEEE2015-2026Engineering and human-computer interaction literatureACM Digital LibraryACM2015-2026CHI, DIS, COMPASS and ICTD proceedings, where much participatory design research with LMIC populations is publishedWHO Global Index MedicusWHO2015-2026Regional literature from LMICs (AIM, LILACS, IMEMR, IMSEAR, WPRIM) under-indexed in other databasesGoogle ScholarGoogle platform2015-2026Supplementary searching; first 200 results screened Databases and information sources to be searched. 10.1371/journal.pone.0337671.t003Table 3Grey literature sources and search approach.Source typeSpecific sourcesApproachPreprint serversmedRxiv; arXiv (cs.HC)Keyword search, 2015–2026Theses and dissertationsProQuest Dissertations & Theses Global; institutional repositories via BASE and COREKeyword searchOrganisational repositoriesWHO IRIS; World Bank Open Knowledge Repository; USAID Development Experience Clearinghouse; UNICEFRepository searchOrganisational websitesPATH; FIND; Digital Square; Global Digital Health NetworkStructured browsing of publications sectionsConference proceedingsACM CHI, DIS, COMPASS, ICTD; IEEE GHTC; AMIACovered via ACM Digital Library, IEEE Xplore, and ScopusTargeted web searchingGoogleFirst 100 results per search string, logged with date searched Grey literature sources and search approach. 10.1371/journal.pone.0337671.t004Table 4Search strategy: overview of facets (full strings for every database are given in S1 Table).#1“Community-based Participatory research”[MeSH] OR UCD OR “user-centered design”[tiab] OR “user centered design”[tiab] OR “human-centered design” OR “human centered design”[tw] OR “design thinking”[tw] ….#2“Digital Health”[Mesh] OR “Telemedicine”[Mesh] OR “Diagnostic Techniques and Procedures”[Mesh] OR “Point-of-Care Testing”[Mesh] OR “Medical Informatics”[Mesh] OR “Cell Phone”[tw] OR “Text Messaging”[tw] OR “digital health”[tw] OR “eHealth” [tw] OR “mHealth”[tw] …#3“Africa”[tw] OR “Asia”[tw] OR “South America”[tw] OR “Central America”[tw] OR “Afghanistan”[tw] OR “Bangladesh”[tw] OR “Benin”[tw] OR “Botswana”[tw] OR “Brazil”[tw] OR “Burkina Faso”[tw] OR “Burundi”[tw] OR “Cambodia”[tw] OR “Cameroon”[tw] OR “Chad”[tw] OR “China”[tw] OR “Colombia”[tw] OR “Congo”[tw] …#4Vulnerable Populations“[Mesh] OR “Medically Underserved Area”[Mesh] OR “Health Services Accessibility”[Mesh] OR “Poverty Areas”[Mesh] OR “Rural Population”[Mesh] OR “Transients and Migrants”[Mesh] OR “Refugees”[Mesh] OR “Indigenous Peoples”[Mesh] OR underserved[tiab] OR “under-served”[tiab] OR marginali*[tiab]…#5#3 OR #4#6#1 AND #2 AND #5 Search strategy: overview of facets (full strings for every database are given in S1 Table). Grey literature searching follows the same date limits and eligibility criteria as the database searches, is conducted by a named reviewer, and is documented with the date searched and the number of records retrieved from each source. Grey literature will be reported as a distinct stream in the PRISMA-ScR flow diagram. Preprints are eligible where no peer-reviewed version exists; where both exist, the peer-reviewed version is retained and the preprint treated as a duplicate. Commercial product documentation and promotional material are not eligible. Records retrieved will be deduplicated in Zotero before screening. Study/Source of evidence selection We will use Covidence to screen records, exporting included titles to Excel for analysis. Two researchers will independently assess articles for inclusion by screening titles, abstracts, and full texts. Where the two independent reviewers disagree on the eligibility of a paper, a third reviewer will adjudicate using the same inclusion criteria. Before full screening, both reviewers will pilot the criteria on a calibration sample of records, with particular attention to the two criteria most open to interpretation: whether a setting meets the definition of a low-resource setting, and whether an innovation includes a digital component. Decision rules will be refined following the pilot, and inter-rater agreement for setting eligibility will be reported. Records excluded on language grounds will be counted and reported by language rather than discarded silently. Data extraction We will use a standardized form (S3 Table) to extract relevant data from the studies included. The following will be extracted: administrative and bibliographic information, study characteristics & context, the nature and details of digital health innovation, the design approaches and processes applied, including the stated methodology, the stages of user involvement, the specific methods used, and the depth of user involvement; the completeness with which the design process is reported; and reported key findings. Data synthesis and presentation We will analyze the data using descriptive statistics and thematic analysis, with results organized in tables and charts and presented into themes that reflect the review objectives. Our thematic analysis will identify patterns and trends in the application of UCD and related participatory design methodologies. Quantitative data, where applicable, will be summarized descriptively. We will also conduct a narrative synthesis of the barriers and facilitators to co-creation and UCD to integrate findings across studies, focusing on methods, outcomes, and identified gaps. Reporting completeness will be described and cross-tabulated by publication year, region, publication type, and stated approach, and the author-applied label will be compared against the recorded depth of user involvement, so that terminological variation is reported as a finding rather than treated as a filter. Findings will be reported separately for studies conducted in low- and middle-income countries and for those conducted with underserved populations in high-income countries, and the principal descriptive results will be presented both including and excluding the latter. Throughout, this review characterizes what studies report. Where relationships between design processes and outcomes are described, these are presented as reported by the original authors; the review does not assess the validity of these claims or establish causal relationships between design approach and outcome. Study status and timeline At the time of this revised submission the review is in progress. This review will be revised and conducted in accordance with the methods described in this revised protocol. An initial search was executed on June 2026 across the databases outlined in this protocol except for the WHO Medicus, retrieving 1809 records. Following peer review of this protocol, the search strategy and eligibility criteria were amended as recorded in Table 5. Because these amendments materially change what the search retrieves, a corrected search will be executed across all databases and information sources in September 2026, and all records will be screened against the revised eligibility criteria; no eligibility decision made under the superseded criteria will be carried forward without re-screening. Both the original and the corrected searches will be reported in the PRISMA-ScR flow diagram of the completed review. 10.1371/journal.pone.0337671.t005Table 5Amendments to the protocol following peer review.DateSection amendedChangeRationale09-08-2026Title; Abstract; throughoutScope reframed from “UCD and co-creation” to UCD and related participatory design methodologies; definitions added (Table 1)Peer review: the framing excluded HCD, co-design, participatory design, and design thinking, which the search and eligibility criteria already admitted09-08-2026Title; Abstract; throughoutPaired phrase “digital health and diagnostics” removed; digital diagnostics treated as a sub-category of digital health, with a digital-component requirementPeer review: diagnostics are a sub-area of digital health, and the pairing was applied inconsistently09-08-2026Review questionsAll questions rewritten and aligned; causal phrasing replaced with “reported to influence”; reporting-completeness question addedPeer review: questions were mutually inconsistent and implied causal inference beyond the scope of a scoping review09-08-2026Inclusion criteriaStudies naming a design approach without describing the activities are now eligible; reporting completeness recorded and reportedPeer review: excluding such studies was inconsistent with the review’s own premise, and their prevalence is itself a finding09-08-2026Inclusion criteriaOperational definition of low-resource setting added, anchored to World Bank classification and to external designations of underservice for high-income settingsPeer review: rurality or underserved status does not by itself constitute a low-resource setting09-08-2026Search strategyNOT block excluding high-income settings removed; underserved-population facet added; hand-built country list replaced with the Cochrane EPOC LMIC filterPeer review: the exclusion would have removed eligible studies of underserved populations in high-income countries09-08-2026MethodsDefinitive list of databases and named grey literature sources specified (Tables 2 and 3); PRISMA-S items reportedPeer review: three inconsistent database lists appeared in the manuscript and grey literature searching was not reproducible Amendments to the protocol following peer review. We anticipate completing screening by December 2026, data extraction by January 2027, and reporting by April 2027. These projections allow for the larger volume of records expected under the broadened eligibility criteria and search strategy. Any deviation from this revised protocol occurring during the conduct of the review will be reported in the final publication, together with its rationale and an assessment of its likely effect on the findings. Strengths and limitations Strengths. This review systematically bridges two distinct but highly relevant fields: participatory design methodologies and the implementation of digital health interventions in low-resource settings. By mapping this intersection, it will provide a foundational overview that is currently absent, identifying convergent principles and applications that can guide future research and funding. It will show where research is being conducted, with whom, and for which types of technology, and will identify gaps; under-represented regions, diseases, and stakeholder groups providing a strategic roadmap for future primary research. By recording the completeness with which design processes are reported, it will also generate the first systematic account of how far the terminology of participatory design in this literature corresponds to described practice. Limitations. The core concepts of participatory design and of low-resource settings are defined and reported inconsistently across the literature. Because studies that invoke a named approach without describing it are eligible, the principal risk is now the converse: studies that use participatory methods without labelling them as such may be missed. We mitigate this through activity-level search terms and reference-list screening, but some omission is likely. This review is restricted to literature published in English and French, reflecting the language capabilities of the review team. This restriction risks under-representing evidence from Spanish- and Portuguese-speaking Latin America, Lusophone Africa, and Arabic- and Chinese-language literature, and therefore introduces a potential geographic bias that is material given the review’s focus on low-resource settings. We partially mitigate this through the inclusion of the WHO Global Index Medicus, which indexes regional databases with English-language abstracts, and we will record and report the number of records excluded on language grounds, disaggregated by language. We anticipate substantial heterogeneity across included studies in the technologies described, the design approaches applied and the depth of user involvement they entail, the outcomes reported and the instruments used to measure them, and the settings in which the work was conducted. This heterogeneity is itself an object of the review, but it limits the comparability of findings across studies and precludes any quantitative pooling or comparative statement about the relative effectiveness of different design approaches. The review’s contribution is accordingly descriptive: it maps the range and distribution of reported practice rather than establishing which approaches produce better outcomes. Consistent with JBI guidance for scoping reviews, we do not undertake critical appraisal of included studies. The review therefore describes what is reported without assessing the methodological quality of the studies or the reliability of the outcomes they report; reported associations between design process and outcome are typically uncontrolled and frequently reported by the design teams themselves, which further constrains what can be inferred. Finally, the boundary between resource-constrained populations in high-income countries and the wider literature on underserved populations involves judgement; the criteria in Appendix I were specified in advance to constrain it, and findings will be presented both including and excluding these studies. Grey literature and Google Scholar searching are not fully reproducible, and results may vary by search date and location. Supporting information Search strategy. (DOCX) Externally defined designations accepted as evidence of a low-resource setting within a high-income country. (DOCX) Data collection instrument. (DOCX) PRISMA-P-checklist__protocol_review. (DOCX) 12 Jun 2026 User-centered design and co-creation for digital health Innovations and diagnostics: A scoping review protocol to explore applications and outcomes in low-resource settings PLOS One Dear Dr. Otukpa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Helen Howard Staff Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following financial disclosure: “This research is funded by the European Health and Digital Executive Agency (HADEA) Project 101057251 – DI-DIDA” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. Could you please revise the manuscript to carefully address the concerns raised? [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Partly ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Partly ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: This protocol proposes a scoping review on the use of user-centred design (UCD) and co-creation methods for digital health interventions in low-resource settings. While this topic is interesting overall, the manuscript has significant issues that should be addressed before publication. Please see below for more specific feedback. Major: 1. The framing and motivation for the scoping review is not clear. In particular, in the introduction, it is not consistently clear that you are focusing on identifying papers that use UCD to design digital health interventions in low-resource settings. You mention digital health early on but then switch to talking about UCD and low-resource settings without digital health. 2. The introduction/framing of the paper only mentions UCD and co-creation but there are many other related methodologies such as co-design, participatory design, human-centred design (HCD), etc. You use the term HCD in line 105 but did not introduce it. The paper would benefit from clearly defining the term(s) you plan to use, and explaining how they relate to other similar methodologies, and explaining in your search strategy how you will capture as many of these as possible. 3. Intro, line 115-119: You have not made a strong case for why UCD and co-creation methodologies would need to be applied differently in a low-resource setting. The factors you list here could impact the success of digital health interventions, but not UCD methods. In fact, I would argue that UCD methods help to overcome these types of challenges in digital health in low-resource settings. 4. Line 148: Your third research question cannot be addressed with your planned methods. You would need to also identify studies that do not use UCD methods in order to compare them. 5. Methods: Your methods are not very clearly explained and are ambiguous in places. For example, the dates that will be included are not clear (some places say 10 year, some say 10-15). It would help to include an overview of the search strategy in the main paper, rather than the appendix (e.g., summarising the main search concepts and synonyms). It would also be helpful to have the databases that will be searched clearly listed (they are currently mentioned across different paragraphs, and a more detailed strategy is needed for Google Scholar which usually returns tens of thousands of results that cannot be systematically screened), as well as the inclusion/exclusion criteria. I would also suggest presenting your methods in the order they will be done. For example, you write that references of included articles will be screened before you have finished describing where the searches will take place. I see that you have checked these items off in the PRISMA checklist, but they did not feel very clear in the protocol. 6. It would be helpful to more clearly define if there are certain types of papers that will be included or excluded. Do they have to measure outcomes to be included? What if they only use co-design methods to develop a digital health tool, but do not evaluate it? Do they need to measure the outcomes you have specifically listed? What if they only mention the use of “UCD” or “co-design” but do not explicitly describe the methods used? Minor comments: 7. Intro: in some areas, this protocol focuses on infectious disease specifically, though this does not seem to be part of the scoping review topic or strategy. I would suggest instead starting the introduction by talking about the burden of preventable diseases in low-resource settings, rather than listing rare infectious diseases of poverty. 8. Intro: Similarly, many of the digital health examples provided are very infectious-disease specific. If you plan to review studies that include all types of digital health tools, I think these examples should be expanded to include those that address health behaviours, chronic diseases, etc. as these are a huge area as well. 9. Line 146: I think this question needs to include “in low-resource settings.” 10. Please clarify how you will you define “low-resource” or “underserved” in high-income countries as part of your inclusion/exclusion criteria. 11. Types of studies: it is not typical to include systematic/scoping reviews in your results, but instead to check their references for relevant studies. 12. Line 175: you mentioned a restriction of 10 years in your abstract but state in Line 175 that you will just “prioritise” publications in 10-15 years but not restrict them. Since this is a systematic search and screening, there is no scope to prioritise – you either need to include the papers or not. Please also choose between 10 or 15 years. If you decide to restrict the strategy, please provide a justification. 13. Search strategy: The search strategy needs refinement – for example, you are missing the other spelling of “human-centred design” and many digital health-relevant terms like electronic medical records, electronic health records, chatbot, etc. 14. Ethics: scoping reviews do not require ethics approval. 15. Extraction table (appendix): it would also be helpful to extract data on the any specific framework that was used by the researchers (e.g., the Double Diamond, IDEAS framework, etc.). This also seems closely related to your first review question. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. 23 Jun 2026 Reviewer comment 1 The framing and motivation for the scoping review is not clear. In particular, in the introduction, it is not consistently clear that you are focusing on identifying papers that use UCD to design digital health interventions in low-resource settings. You mention digital health early on but then switch to talking about UCD and low-resource settings without digital health. Response: We agree that the introduction did not consistently hold the three core concepts; UCD/co-creation, digital health and diagnostics, and low-resource settings in view simultaneously, drifting into a generic account of UCD. We have rethreaded the introduction so the specific intersection that defines the review is foregrounded throughout, re-anchoring the UCD and co-creation paragraphs to digital-health/diagnostic examples in low-resource settings, and adding an explicit scope statement. Action taken: Revised the Introduction and Rationale to re-anchor each design paragraph to digital health/diagnostics in low-resource settings and added an explicit closing scope sentence specifying that the review focuses on studies applying UCD/co-creation to the design of digital health and diagnostic innovations in low-resource settings. The objective and review questions were aligned to mirror this framing. Reviewer comment 2 The introduction/framing of the paper only mentions UCD and co-creation but there are many other related methodologies such as co-design, participatory design, human-centred design (HCD), etc. You use the term HCD in line 105 but did not introduce it. The paper would benefit from clearly defining the term(s) you plan to use, and explaining how they relate to other similar methodologies, and explaining in your search strategy how you will capture as many of these as possible. Response: We agree. We have added a short terminology paragraph defining the two organizing constructs we adopt (UCD and co-creation), naming the adjacent methodologies (HCD, design thinking, co-design, co-production, participatory design, community-based participatory research), and explaining how they relate as a partly overlapping continuum of user involvement. We introduce HCD explicitly at first use and clarify that our search deliberately captures the full terminological family. Action taken: Added a terminology/conceptual-scope paragraph to the Introduction; introduced “human-centered design (HCD)” at first use (tracked change); and clarified in the Search strategy and Appendix I that Concept Block 1 is constructed to capture the full family of related terms regardless of the label authors use. Reviewer comment 3 Intro, line 115-119: You have not made a strong case for why UCD and co-creation methodologies would need to be applied differently in a low-resource setting. The factors you list here could impact the success of digital health interventions, but not UCD methods. In fact, I would argue that UCD methods help to overcome these types of challenges in digital health in low-resource settings. Response: We fully accept this point, which has strengthened our argument. We have rewritten the rationale so that contextual factors (infrastructure, literacy, connectivity, socio-cultural diversity) are no longer presented as obstacles to the methods, but as precisely the realities UCD and co-creation are suited to navigate. The genuine gap is relocated to the evidence base: the lack of a consolidated picture of how these methods are applied in low-resource settings and with what outcomes. Action taken: Rewrote the Rationale passage (tracked change): the deleted clause framing contextual factors as impeding the methods is replaced with text positioning UCD/co-creation as well suited to these settings and locating the gap in the under-consolidated evidence on application and outcomes. Reviewer comment 4 Your third research question cannot be addressed with your planned methods. You would need to also identify studies that do not use UCD methods in order to compare them. Response: The reviewer is correct. A comparison with non-co-creative approaches would require including comparator studies outside our inclusion criteria and beyond the descriptive intent of a scoping review. We have revised RQ3 to remove the explicit comparison and to focus on characterizing the outcomes reported within included UCD/co-creation studies, including how they are measured and which are sustained. Any within-study comparisons that appear will be summarized narratively. Action taken: Revised RQ3 (tracked change) to: “What outcomes intended and unintended are reported in association with UCD and co-creation in digital health and diagnostic innovations in low-resource settings, how are these outcomes measured and reported?, and which are sustained over time?” The comparison clause was deleted. Reviewer comment 5 Methods: Your methods are not very clearly explained and are ambiguous in places. For example, the dates that will be included are not clear (some places say 10 year, some say 10-15). It would help to include an overview of the search strategy in the main paper, rather than the appendix (e.g., summarising the main search concepts and synonyms). It would also be helpful to have the databases that will be searched clearly listed (they are currently mentioned across different paragraphs, and a more detailed strategy is needed for Google Scholar which usually returns tens of thousands of results that cannot be systematically screened), as well as the inclusion/exclusion criteria. I would also suggest presenting your methods in the order they will be done. For example, you write that references of included articles will be screened before you have finished describing where the searches will take place. I see that you have checked these items off in the PRISMA checklist, but they did not feel very clear in the protocol. Response: We have revised the Methods comprehensively: standardized the eligibility window to 1 January 2015 – 31 December 2025; added a main-text overview of the three search concept blocks with representative synonyms (full strings in Appendix I); consolidated all databases and supplementary sources into a single list; specified a bounded, reproducible Google Scholar procedure; added explicit inclusion and exclusion criteria; and reordered the stages into execution sequence, moving reference-list/citation searching to after the database searches. Action taken: Edited the abstract and Methods date language to a single firm window (tracked changes); corrected the framework attribution (see below); added the Types-of-studies/eligibility rewrite; and removed the duplicated synthesis section. Note: this comment also surfaced two latent inconsistencies we corrected the framework was mis-attributed (“JBI methodology... as updated by Levac et al.”; Levac et al. extends the Arksey & O’Malley framework, not JBI), now corrected to “JBI methodology for scoping reviews” with reporting per PRISMA-ScR; and the document contained two near-identical synthesis sections (“Data synthesis and presentation” and “Data analysis and presentation”), the duplicate of which has been deleted. Additionally we have included an overview of the search strategy within the text and specified the strategy for search for google scholar. Reviewer comment 6 Do they have to measure outcomes to be included? What if they only use co-design methods... but do not evaluate it?... What if they only mention the use of “UCD” or “co-design” but do not explicitly describe the methods used? Response: As a direct response, no, outcomes do not have to be measured. We have added explicit decision rules: (i) outcome measurement is not required for inclusion, since the review maps application; (ii) design-only studies are included, with the development stage recorded at extraction; (iii) the listed outcomes are illustrative of what we extract where present, not an inclusion threshold; and (iv) studies that merely name a label without describing any user-involvement activity are excluded, per a minimum-activity operational definition. Action taken: Added the eligibility rules to the Types-of-studies/eligibility text (tracked change), including the minimum user-involvement-activity threshold and the explicit statement that formal evaluation is not required. The abstract inclusion wording was softened from “report on outcomes” to “where reported, outcomes” to remove the contradiction. Reviewer comment 7 Intro: in some areas, this protocol focuses on infectious disease specifically, though this does not seem to be part of the scoping review topic or strategy. I would suggest instead starting the introduction by talking about the burden of preventable diseases in low-resource settings, rather than listing rare infectious diseases of poverty. Response: We agree. We have rewritten the opening to motivate the review through the broader burden of preventable disease (communicable and non-communicable) and the systemic diagnostic/access gaps that digital health can help address. Specific infectious diseases are retained only as brief illustrations of digital diagnostic application, not as a statement of scope. Action taken: Rewrote the opening paragraph (tracked change) to lead with the burden of preventable disease across communicable and non-communicable conditions and corrected the definitional error “non-infectious diseases (NCDs)” to “non-communicable diseases (NCDs).” Reviewer comment 8 Intro: Similarly, many of the digital health examples provided are very infectious-disease specific. If you plan to review studies that include all types of digital health tools, I think these examples should be expanded to include those that address health behaviours, chronic diseases, etc. as these are a huge area as well. Response: We agree and have broadened the illustrative examples to span non-communicable and chronic-disease management, health-behavior change and prevention, maternal and reproductive health, and mental health, alongside the existing infectious-disease diagnostic examples, presented explicitly as illustrations of the breadth the review will map. Action taken: Expanded the digital-health example paragraphs (reflected in the broadened Introduction framing). We also corrected the word-order error “innovations digital health” to “digital health innovations” (tracked change), and flag for the editor that reference [6] supporting a point-of-care accuracy claim is a non-peer-reviewed source we are replacing. Reviewer comment 9 Please clarify how you will you define “low-resource” or “underserved” in high-income countries as part of your inclusion/exclusion criteria. Response: We have added an operational definition with two pathways: (i) LMICs classified using the World Bank income classification for the study year; and (ii) resource-constrained or underserved populations/sub-national areas within high-income countries, evidenced by indicators such as rural/remote populations, designated medically underserved areas, displaced or migrant populations, indigenous communities, or author-defined underserved groups, with a materiality requirement and reviewer adjudication for ambiguous cases. Action taken: Added the operational definition to the eligibility criteria; corrected the extraction instrument (Appendix II, Section B) income-level options, where “Lower middle income” was duplicated and “Low income” omitted the first instance is changed to “Low income” (tracked change) and added a field recording the basis for the low-resource/underserved classification. Reviewer comment 10 …it is not typical to include systematic/scoping reviews in your results, but instead to check their references for relevant studies. Response: We agree. Existing reviews are no longer included as primary results; their reference lists will be screened to identify relevant primary studies, and they may inform background/contextual discussion. This avoids double-counting underlying primary studies. Action taken: Revised the Types-of-studies criterion (tracked change) to exclude reviews as records while retaining them for reference-list screening and background; added a citation-screening step after the database searches; and removed “Review” from the extractable study-design options in Appendix II. Reviewer comment 11 You mentioned a restriction of 10 years in your abstract but state... that you will just “prioritize” publications in 10-15 years but not restrict them... Please also choose between 10 or 15 years. If you decide to restrict the strategy, please provide a justification. Response: We agree on both points. We have removed all “prioritization” language and adopted a single firm window of 1 January 2015 – 31 December 2025 (a 10-year period), applied as a hard database-level limit and enforced consistently throughout, with a justification added. Action taken: Replaced the “no strict restriction... prioritizing... last 10–15 years” sentence with a firm 2015–2025 inclusion rule and justification (tracked change), and aligned the abstract date language (“within the last 15 years” → “between 2015 and 2025”). All other date references were reconciled. Reviewer comment 12 Search strategy: The search strategy needs refinement. You are missing the other spelling of “human-centered design” and many digital health-relevant terms like electronic medical records, electronic health records, chatbot, etc. Response: We have systematically revised Appendix I to include British/American and hyphenation variants for every design term (including both spellings of “human-centered/centered design”) and substantially expanded the digital-health block with the missing concepts electronic health/medical records (EHR/EMR), clinical decision support, chatbot/conversational agent, artificial intelligence/machine learning, remote/digital monitoring, wearables/sensors, and digital/computational diagnostics, among others. We have added a statement that the strategy will be peer-reviewed using the PRESS checklist before execution. Action taken: Revised Appendix I (Concept Blocks 1 and 2) to add spelling/hyphenation variants and the additional digital-health terms; corrected typographical errors in Block 1 (“percon-centered”, unmatched bracket) and inserted explicit Boolean operators between synonym groups; and added a PRESS peer-review statement to the Methods. The main overview now reflects the expanded terms. Reviewer comment 13 It would also be helpful to extract data on any specific framework that was used by the researchers (e.g., the Double Diamond, IDEAS framework, etc.). This also seems closely related to your first review question. Response: We agree and have added a dedicated extraction field for the specific named framework/model applied (distinct from the broad methodology), seeded with common options (Double Diamond, Design Thinking/d.school, ISO 9241-210, IDEAS, Stanford Biodesign, EBCD, CeHRes Roadmap, etc.) plus “Other (specify)” and “None named.” We have noted in the synthesis that the distribution of these frameworks will be analyzed to answer RQ1. Action taken: Added the “Specific design framework/model used” field to Appendix II, Section D; sharpened RQ1 to reference frameworks/models with examples (tracked change); and linked the new field to RQ1 in the Data synthesis section. Reviewer comment 14 Ethics: scoping reviews do not require ethics approval. Response: We agree that a literature-based scoping review does not require research-ethics approval. We have clarified this in the Ethics and dissemination section and reframed the institutional and national approvals as program-level (DI-DIDA) context reported for completeness, while retaining the dissemination and protocol-amendment statements. Action taken: Added a leading sentence to the Ethics section (tracked change) stating that the review does not in itself require ethics approval, with the SU-ISERC/NACOSTI approvals reframed as broader-project context. Reviewer comment 15 I think this question needs to include “in low-resource settings.” At Line 146 Response: We agree and have added the scope clause. We also confirmed that all three review questions are now consistently bounded to low-resource settings and that the phrasing “low Submitted filename: Response to reviewers_UCD PROTOCOL.docx 4 Aug 2026 Dear Dr. Otukpa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 18 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Alejandro F. Mac Cawley, Ph.D. Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The reviewers have raised some remaining issues that should be addressed. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: The authors have responded to many of my earlier comments and the manuscript is improved. However, there are still some remaining issues that should be addressed in order for this protocol to be clearly reported, rigorous, and replicable. Please see below for my additional feedback: 1. Line 59: Given the global focus of the review, the frequent mentions of SSA in the Intro don’t make sense. I would suggest moving away from SSA and describing challenges across LMICs more broadly. 2. Intro: The introduction still does not define HCD or discuss it in relation to other defined concepts like UCD or co-creation (Line 172). The justification for the focus on UCD and co-creation is also not very strong – why have UCD and co-creation been chosen as the focus, but not HCD or any other participatory methods? The framing needs to be very clear – if all of these methods are included in the review, then more elaboration is needed on the group of methods as a whole, rather than only highlighting two approaches. You could consider replacing “UCD and co-creation” throughout the paper with “UCD and related methodologies” or similar. 3. Line 166: there is a typo where what should be one sentence has been broken into multiple sentences. 4. Line 191: questions 1 and 2 do not mention UCD, though this was one of the main methodologies identified in the Intro. Again, it would be helpful to define a specific focus (I would advocate for including all participatory approaches together for a scoping review of this nature), then to be sure it is consistently applied across the research questions, search methods, etc. 5. Line 203: couldn’t “diagnostic innovations” already fit under the umbrella of digital health? It feels like you are mentioning a sub-area of digital health somewhat randomly, and only in some places of the protocol. This also applies to the title. 6. Line 210: From “Particularly…” onwards - you do not need to talk about these aspects of the inclusion criteria in the “population/setting” section. They fit better in later sections. 7. Line 233: I would argue that including papers that explicitly state they have used these methods but without describing the relevant activities should be included, given your point in the introduction about this being a problem in the field. This seems that it would then be a finding of your review if some proportion of the papers mention UCD/HCD/co-design, etc. but do not explicitly describe their methods. 8. Line 242: Search should not stop at 2025, but should go until the present 9. Line 251: reference needed for JBI 10. Line 260: do you mean “peer-reviewed literature” or “academic literature” and “grey literature” instead of “published” and “unpublished”? 11. Line 276: I don’t think #6 should be included in your search – this could exclude relevant papers that refer to high-resource settings, or papers in high-income countries that focus on low-resource communities or populations. Similarly, if you want to include papers focused on underserved communities in high-income settings, as stated in your Methods, you should include search terms related to these populations (e.g., underserved, low-income, marginalised, etc.) 12. Line 305: the editor can make the final call here, but I don’t think you need to mention these ethics approvals – they are not relevant for this scoping review and just take up unnecessary space, in my opinion. 13. Line 318: it appears that this search has already been conducted, but this is concerning as I have identified issues with the search terms that I think need to be corrected before the scoping review is completed. 14. Line 493: You should state in the protocol where the list of LMICs came from (e.g. World Bank classification and year) – this is currently only in your response to my comment, but not in the Methods. 15. Line 271: “In several electronic databases” is vague - it is still not very clear which databases will be searched. It is also not yet clear how grey literature will be located, as “grey literature sources” is quite vague too. 16. Appendix: you are missing search terms with the British spelling of “human-centred” and “user-centred” Reviewer #2: - The introduction is well structured and clearly motivates the review. However, some technology-specific examples (e.g., malaria diagnostics, wearable monitoring, and point-of-care technologies) are described in greater detail than is necessary for a protocol. As the review focuses on UCD and co-creation rather than digital health technologies themselves, these examples could be condensed to place greater emphasis on the conceptual rationale and the implementation challenges motivating the review. - The operational definition of “low-resource settings” requires further clarification. The eligibility criteria currently include LMICs as well as rural or underserved areas in high-income countries, but it is not clear why the latter are included or how they will be identified during screening. Rurality or underserved status does not necessarily equate to a low-resource setting. The authors should either (i) adopt a standard definition (e.g., World Bank LMIC classification), or (ii) provide a clear conceptual and operational justification for extending the review to resource-constrained populations within high-income countries, including explicit eligibility criteria. - The “Study status and timeline” section appears to contain projected dates that have now passed. Please update this section to reflect the current status of the review (e.g., whether the literature search, screening, or data extraction have been completed). If the review has progressed since the protocol was first submitted, it would be helpful to clarify that the protocol continues to reflect the methods that were followed, and that any deviations will be reported in the final review. - RQ2 asks: “How do co-creation processes influence…”. But, a scoping review maps reported evidence rather than demonstrating causal influence. A more cautious wording could be: “How are co-creation processes reported to influence…”. - limitations may also acknoledge language restriction (English/French), and the anticipated heterogeneity of interventions, co-creation approaches, and reported outcomes, which may limit the comparability of findings. Reviewer #3: I have carefully examined both the authors' response to the previous reviewer and the revised manuscript. The authors have made substantial efforts to address the concerns raised, and the manuscript has improved considerably. In particular, the scope of the review is now more clearly defined, the rationale is better aligned with the stated objectives, the review questions are more appropriate for a scoping review methodology, and the methodological description is more transparent and reproducible. The revised protocol is generally well organised and follows accepted guidance for scoping reviews. Overall, these revisions adequately address the substantive concerns raised by the previous reviewer. I only have a small number of minor observations before acceptance. 1. The Introduction remains somewhat lengthy- Although the broader examples of digital health have improved the manuscript, several sections describing individual technologies (for example wearable technologies, disease-specific examples and technical descriptions) appear more detailed than is necessary for a protocol. Some condensation would improve readability without affecting the scientific contribution. This is an editorial suggestion rather than a methodological concern. 2. The rationale could be slightly more concise- While the rationale is now much stronger, there remains some repetition around the value of documenting UCD/co-creation and the need for evidence mapping. Streamlining this section would improve flow. 3. A final proofread would be beneficial- I noticed occasional grammatical and stylistic inconsistencies (for example punctuation, sentence flow and wording) that would benefit from careful copy-editing prior to publication. These do not affect the scientific content but would improve readability. The authors have responded appropriately and comprehensively to the previous review. The remaining observations are minor editorial suggestions rather than substantive methodological concerns. I therefore recommend acceptance after minor editorial revisions. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Maneesh Kumar ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. 10 Aug 2026 We thank the Editor and the three Reviewers for the time and care taken with this protocol. The comments were detailed and constructive and addressing them has led to substantive improvements in the coherence and reproducibility of the review in particular to the framing of the design methodologies under study, the internal consistency of the scope statement, the eligibility criteria, the search strategy, and the accuracy with which we report the status of the work. Below we respond to each of the comments in turn. Reviewers' comments are reproduced verbatim; each response is followed in blue by a description of the corresponding changes to the manuscript. Revised text is quoted where it aids review. In the manuscript itself, all changes are marked using tracked changes. Where two or more Reviewers raised related points and in one instance where their recommendations pulled in opposite directions we have addressed them together and flagged the connection, so that the coherence of our revisions can be assessed across the reviews as a whole. Reviewer #1: The authors have responded to many of my earlier comments and the manuscript is improved. However, there are still some remaining issues that should be addressed for this protocol to be clearly reported, rigorous, and replicable. Please see below for my additional feedback: 1. Line 59: Given the global focus of the review, the frequent mentions of SSA in the Intro don’t make sense. I would suggest moving away from SSA and describing challenges across LMICs more broadly. Thank you for this keen observation. On a re-examination, we do fine the framing of the Introduction inconsistent with the scope of the review, which is defined at the level of low-resource settings rather than any single region. The repeated references to sub-Saharan Africa were a legacy of the regional focus of the parent DI-DIDA project and were not intended to narrow the review. We have revised the Introduction to describe the disease burden, health-system constraints, and diagnostic gaps across low- and middle-income countries and other low-resource settings more broadly. Sub-Saharan Africa is retained only where a cited source reports region-specific data, and in those instances, it is presented as an illustrative example rather than as the framing of the review. We have also checked the Rationale and Inclusion criteria to confirm that the population and setting framing is now consistent throughout. Specifically; • Introduction, paragraph 2: burden and health-system text re-cast at LMIC level. Revised text reads: “These conditions account for a substantial share of deaths worldwide, with the burden concentrated in low- and middle-income countries (LMICs) [3]. This is partly a consequence of persistent health-system constraints in these settings — including infrastructure, financing, and human-resource limitations — that restrict the adoption and impact of medical and diagnostic technologies [4].” • Point-of-care testing paragraph: both references to sub-Saharan Africa replaced with “low-resource settings” and “these settings”; the sentence fragment beginning “Ensuring the relatively accurate testing…” merged into the preceding sentence. • Reference [4] (a sub-Saharan Africa–specific analysis) is now signaled as regional evidence and paired with an LMIC-wide source supporting the general claim. • A sentence has been added stating that “low-resource settings” as used in this review includes underserved populations within high-income countries, consistent with the Inclusion criteria and with the revised search strategy. 2. Intro: The introduction still does not define HCD or discuss it in relation to other defined concepts like UCD or co-creation (Line 172). The justification for the focus on UCD and co-creation is also not very strong – why have UCD and co-creation been chosen as the focus, but not HCD or any other participatory methods? The framing needs to be very clear – if all of these methods are included in the review, then more elaboration is needed on the group of methods as a whole, rather than only highlighting two approaches. You could consider replacing “UCD and co-creation” throughout the paper with “UCD and related methodologies” or similar. We appreciate the Reviewer for pressing us on this point, which has led to a clearer and more defensible framing of the review. Our intention was never to exclude HCD, co-design, participatory design, or design thinking: our search strategy already contains terms for each of these, and our operational definition of eligibility turns on the user-involvement activities a study describes rather than on the label it applies. The framing in the Introduction did not reflect this. The Reviewer is correct that HCD was invoked without definition and that our emphasis on two named approaches was inconsistent with an eligibility criterion that is, in practice, method-agnostic. We have addressed the comment in three ways. First, we have added a paragraph to the Introduction defining the family of participatory and user-involving design methodologies UCD, HCD, co-creation, co-design, participatory design, and design thinking setting out what they share (iterative development grounded in users’ contexts) and where they differ (principally in the depth of user involvement, from consultation through to equitable partnership), supported by a new table of working definitions. Second, we have adopted the umbrella phrasing the Reviewer suggests, using “UCD and related participatory design methodologies” as the framing term and reserving specific labels for places where a specific approach is meant. Third, we have made explicit that we do not treat these labels as reliable markers of practice: because the terminology is applied inconsistently, eligibility decisions rest on the activities a study describes, and the author-applied label is recorded as an extraction variable so that terminological variation becomes a finding of the review rather than a filter upon it. Specifically; • Introduction: the three-sentence terminology passage replaced with a full definitional paragraph covering UCD, HCD, participatory design, co-design, co-creation, and design thinking, and the continuum of user involvement that distinguishes them. HCD is now defined at first use. • New Table 1 added (“Working definitions of user-involving design approaches”), with columns for term, working definition, distinguishing emphasis, and key source; the search strategy table renumbered accordingly. • Umbrella phrasing adopted throughout the title, Abstract, Rationale, Objectives, review questions, Inclusion criteria, Data extraction, Data synthesis, and Strengths and limitations. • Rationale: justification for covering the family strengthened. Added text reads: “We include the full family of user-involving design approaches rather than a single named method because the terminology is used inconsistently across this literature: studies applying substantively similar methods describe them variously, and studies invoking the same label may describe very different depths of user involvement. Restricting the review to one or two labels would therefore fragment a body of evidence that is methodologically continuous, and would systematically miss relevant work.” • Inclusion criteria: a sentence added drawing the outer boundary of the family — approaches applied to the design or development of a digital health innovation are eligible; participatory approaches applied solely to service delivery or research governance, with no associated technology, are not. • Appendix II, Section D: “Stated Methodology/Framework” converted from free text to a coded list (UCD / HCD / co-design / co-creation / participatory design / design thinking / CBPR / other / none stated), with a parallel free-text field capturing the authors’ verbatim wording. 3. Line 166: there is a typo where what should be one sentence has been broken into multiple sentences. We appreciate that you pointed this out, such errors have the potential to confuse the reader and dampen the message. We have corrected this as appropriate. 4. Line 191: questions 1 and 2 do not mention UCD, though this was one of the main methodologies identified in the Intro. Again, it would be helpful to define a specific focus (I would advocate for including all participatory approaches together for a scoping review of this nature), then to be sure it is consistently applied across the research questions, search methods, etc. We thank the Reviewer for this observation and for the accompanying recommendation, which we have adopted. Indeed, our review questions were not fully in line with the Introduction: questions 1 and 2 referred only to co-creation, question 3 to “UCD and co-creation”, while the eligibility criteria and search strategy were in fact broader than both. Following the Reviewer’s advice, and consistent with our response to Comment 2, we have adopted the full family of participatory and user-involving design approaches as the explicit scope of the review and have rewritten the review questions so that this scope is applied uniformly. We have additionally conducted a consistency audit across the title, Abstract, Objectives, review questions, Inclusion criteria, search strategy, and data extraction instrument to confirm that a single scope statement is now used throughout, and have aligned the description of innovation types across all three questions, which was also previously inconsistent. Specifically: • Review questions reworded. The revised questions read: • What participatory and user-involving design approaches e.g. UCD, HCD, co-design, participatory design, and co-creation and which named frameworks, processes, or models (e.g. the Double Diamond, IDEAS, the ISO 9241-210 cycle) are applied in the development of digital health innovations for low-resource settings, and how does their use vary across regions, healthcare contexts, and technology types? • How are participatory and user-involving design processes reported to influence the design and functionality of digital health innovations in low-resource settings — at which stages of the development lifecycle, using which methods, with which stakeholder groups, and at what depth of user involvement? • What outcomes, intended and unintended (e.g. usability, acceptability, adoption, clinical accuracy, scalability, sustainability), are reported in association with these approaches in digital health innovations in low-resource settings, and how are these outcomes defined, measured, and reported? ******A further sub-question has been added in response to Comment 5: How completely are participatory design processes reported in this literature, and what proportion of studies invoke a named approach without describing the activities undertaken? • Objectives section and Abstract (Objective and Inclusion criteria) revised to carry the same scope statement. • Consistency audit completed across all sections naming the scope; the eligibility paragraph under “Types of studies”, which was already method-agnostic, is unchanged in substance. • Formatting corrected: the review questions and the Inclusion criteria headings had been formatted as a single continuous numbered list and are now correctly structured. 5. Line 203: couldn’t “diagnostic innovations” already fit under the umbrella of digital health? It feels like you are mentioning a sub-area of digital health somewhat randomly, and only in some places of the protocol. This also applies to the title. We thank the Reviewer for bringing this up and respectfully push back on the point. Digital diagnostics are indeed a sub-category of digital health, and our paired phrasing “digital health and diagnostics” only appeared redundant (not all diagnostic technologies have a digital component) however, our scope is limited to diagnostic innovations with a digital component for example smartphone-based microscopy, AI-assisted image analysis, connected point-of-care readers, and digitally enabled diagnostic decision support all of which fall within the definition of digital health we adopt. Purely analogue diagnostic tests without a digital component are not eligible. We have therefore removed the paired construction throughout and now refer consistently to digital health innovations, and we have amended the title accordingly. To preserve transparency without reintroducing redundancy, we retain digital diagnostics as an explicitly named category within our taxonomy of eligible digital health interventions, and we state once, in the Rationale, that the review pays particular attention to diagnostic applications given the persistent diagnostic gap in low-resource settings and the framing of the wider DI-DIDA project. Innovation type is recorded at extraction, so the distribution of diagnostic and other digital health applications will be reported as a finding rather than asserted as a scope boundary. Specifically • Title revised to remove “and diagnostics”; the revised title reads: “User-centred design and related participatory approaches in digital health innovation for low-resource settings: a scoping review protocol”. • Paired phrasing removed from the Abstract (Objective and Methods), review question 3, the Data extraction section, and Strengths and limitations. • Abstract, Introduction: the sentence narrowing the evidence gap to diagnostics rewritten to describe the gap across digital health innovation as a whole. • Inclusion criteria, Context: the intervention list now names “digitally enabled diagnostics and point-of-care testing” alongside eHealth, mHealth, telehealth, and wearables, and an explicit exclusion has been added: i. Diagnostic tests without a digital component (e.g. conventional lateral-flow rapid diagnostic tests read by eye) are not eligible unless the innovation includes a digital element such as automated reading, image capture and analysis, connectivity, or data capture. ii. Rationale: one sentence added stating the review’s particular attention to diagnostic applications and the reason for it. • Appendix II, Section C retitled “Digital Health Innovation (details)”; technology-type options reviewed to confirm each is unambiguously digital. • Search strategy: the diagnostic terms are retained without a digital qualifier to preserve sensitivity; the Study selection section now states that the digital-component requirement is applied at screening. 6. Line 210: From “Particularly…” onwards - you do not need to talk about these aspects of the inclusion criteria in the “population/setting” section. They fit better in later sections. This is a keen observation and important in the logical flow of the paper, thank you for highlighting it. It has been implemented. 7. Line 233: I would argue that including papers that explicitly state they have used these methods but without describing the relevant activities should be included, given your point in the introduction about this being a problem in the field. This seems that it would then be a finding of your review if some proportion of the papers mention UCD/HCD/co-design, etc. but do not explicitly describe their methods. We thank the Reviewer for this insight, which we found persuasive. The Reviewer is correct that our exclusion rule was in tension with our own framing: having argued that inconsistent and superficial use of participatory design terminology is a recognized problem in this field, it was inconsistent to then remove from the review precisely those studies that exemplify it. We have revised the eligibility criteria so that studies claiming the use of a named participatory or user-involving design approach are eligible whether they describe the underlying activities. A study is now eligible if it reports the development, adaptation, or evaluation of a digital health innovation in a low-resource setting and either (a) describes at least one concrete user-involvement activity, or (b) explicitly claims the use of a named user-involving design approach without describing the activities undertaken. We have added an extraction variable classifying each included study by the completeness of its reporting fully described, partially described, or label-only and will report this distribution Submitted filename: Response to reviewers_UCD PROTOCOL_REVISED.docx 19 Aug 2026 User-centered design and related participatory approaches in digital health innovations for low-resource settings: A scoping review protocol PONE-D-25-59947R2 Dear Dr. Otukpa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Alejandro F. Mac Cawley, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #2: I appreciate the authors' careful and comprehensive responses. The manuscript has improved substantially, particularly in the conceptual framing, operational definition of low-resource settings, clarification of the study status, refinement of the review questions, and transparency of the protocol limitations. I believe the major methodological concerns raised in the previous review have been satisfactorily addressed. Before publication I recommend one final consistency review to ensure that terminology is used uniformly throughout, particularly for:UCD and related participatory design approaches, digital health innovations, low-resource settings etc. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** PONE-D-25-59947R2 PLOS One Dear Dr. Otukpa, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS One Editorial Office Staff on behalf of Dr. Alejandro F. Mac Cawley Academic Editor PLOS One